Notch Therapeutics Competitors and Similar CompaniesClear all
Notch Therapeutics's competitors and similar companies include Foghorn Therapeutics, Coherus Oncology, ImmPACT-Bio and Alpha Tau Medical.
 Notch Therapeutics Notch Therapeutics is an immune cell therapy company developing a pipeline of off-the-shelf, genetically tailored T cell therapeutics. |  Foghorn Therapeutics Foghorn Therapeutics is a developer of gene therapies for hematologic cancers and solid tumors. |  Coherus Oncology Coherus BioSciences is a biopharmaceutical company that focuses on the research, development, and commercialization of cancer treatments. |  ImmPACT-Bio ImmPACT-Bio is a company that develops a chimeric antigen receptor T-cell (CAR-T) therapy. |  Alpha Tau Medical Alpha Tau Medical focuses on research, development, and commercialization of diffusing alpha-emitters radiation therapy (DaRT) for the treatment of solid cancer tumors. | |
Founding Date | Founding Date 2018 | Founding Date 2016 | Founding Date 2010 | Founding Date 2017 | Founding Date 2016 |
Type | Type Private | Type Public | Type Public | Type Private | Type Private |
Tags | |||||
Locations | Locations Toronto, CA HQ Vancouver, CA | Locations Cambridge, US HQ Cambridge, US | Locations Redwood City, US HQ Camarillo, US | Locations Camarillo, US HQ Rishon Le Tsiyon, IL | Locations Tel Aviv-Yafo, IL HQ Boston, US |
Employees | Employees 257% decrease | Employees 1123% decrease | Employees 14736% decrease | Employees 845% decrease | Employees 1041% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 452 m | Valuation ($) 85.6 m | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $30.9m (FY, 2025) | Revenue (est.) $42.2m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A |
Net income | Net income N/A | Net income ($74.4m) (FY, 2025) | Net income $168m (FY, 2025) | Net income N/A | Net income N/A |
Funding | |||||
Latest funding round | Latest funding round $ 85m (over 5 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 18m (almost 6 years ago) | Latest funding round $ 26m (about 6 years ago) |
Total funding raised | Total funding raised $ 85m | Total funding raised $ 50m | Total funding raised $ 174.5m | Total funding raised $ 18m | Total funding raised $ 55m |
For sources of this data, please see the company profile
View Company Profiles
Foghorn Therapeutics
HQ
Cambridge, US
Employees
112↓ 3% decrease
Foghorn Therapeutics is a developer of gene therapies for hematologic cancers and solid tumors.
View companyCoherus Oncology
HQ
Redwood City, US
Employees
147↓ 36% decrease
Coherus BioSciences is a biopharmaceutical company that focuses on the research, development, and commercialization of cancer treatments.
View companyImmPACT-Bio
HQ
Camarillo, US
Employees
84↓ 5% decrease
ImmPACT-Bio is a company that develops a chimeric antigen receptor T-cell (CAR-T) therapy.
View companyAlpha Tau Medical
HQ
Tel Aviv-Yafo, IL
Employees
104↑ 1% increase
Alpha Tau Medical focuses on research, development, and commercialization of diffusing alpha-emitters radiation therapy (DaRT) for the treatment of solid cancer tumors.
View company